Tomas Corcoran
Royal Perth Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Tomas Corcoran as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:35 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05072314 · Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) TrialMonash University · recruiting · Breast Cancer, Breast Cancer Female, Breast Conserving Surgery · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in breast cancer, ranked by citations from NIH iCite, fetched 2026-11-12 13:35 UTC. The ranking covers the 200 most relevant of 2 PubMed records, and a shared surname and initials can bring in a namesake. All 2 on PubMed
- A pilot multicentre randomised controlled trial of lidocaine infusion in women undergoing breast cancer surgery.Anaesthesia · 202117 citationsRCR 1.4
- Serum lidocaine (lignocaine) concentrations during prolonged perioperative infusion in patients undergoing breast cancer surgery: A secondary analysis of a randomised controlled trial.Anaesth Intensive Care · 20232 citationsRCR 0.4